Therefore, we examined S100A11 protein expression upon TSN silencing in the A549 NSCLC cells, and found significant downregulation of S100A11 at the protein level in both cisplatin-treated and non-treated cells (Fig. 3A). Here, S100A11 is linked to non-small cell lung carcinoma.